» Articles » PMID: 9356569

What Happens to Anxiety Levels on Giving Up Smoking?

Overview
Journal Am J Psychiatry
Specialty Psychiatry
Date 1997 Nov 14
PMID 9356569
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: DSM-IV lists increased anxiety as a nicotine withdrawal symptom. Increased anxiety has been reported to follow smoking cessation in most but not all studies. Indeed, there is some evidence for a reduction in anxiety, compared with precessation levels, after the first few weeks of abstinence. This study reports data from 101 smokers who attempted to stop smoking and who satisfied DSM-III-R criteria for nicotine dependence.

Method: Unlike most studies in this area, a strict criterion of lapse-free abstinence was adopted. It is argued that lapses during an attempt at cessation may underlie a transient increase in anxiety. Anxiety was measured both by a single rating typical in withdrawal studies and by the State-Trait Anxiety Inventory--State Form X. Patients were rated 2 weeks and 1 week before cessation, immediately before cessation, 24 hours after cessation, and 1, 2, 3, and 4 weeks after cessation.

Results: Seventy patients were abstinent for the 4-week follow-up period. There was no evidence of an increase in anxiety following smoking cessation. However, there was a significant decrease in anxiety from the first week of abstinence.

Conclusions: The results weaken the view that increased anxiety is a robust and central element of the nicotine withdrawal syndrome and suggest that giving up smoking is quite rapidly followed by a reduction in anxiety that may reflect removal of an anxiogenic agent, nicotine.

Citing Articles

Combining neuroimaging and brain stimulation to test alternative causal pathways for nicotine addiction in schizophrenia.

Du X, Choa F, Chiappelli J, Bruce H, Kvarta M, Summerfelt A Brain Stimul. 2024; 17(2):324-332.

PMID: 38453003 PMC: 11445730. DOI: 10.1016/j.brs.2024.02.020.


Tobacco Smoking during Pregnancy: Women's Perception about the Usefulness of Smoking Cessation Interventions.

Almeida R, Barbosa C, Pereira B, Diniz M, Baena A, Conde A Int J Environ Res Public Health. 2022; 19(11).

PMID: 35682178 PMC: 9180849. DOI: 10.3390/ijerph19116595.


Perceived stress and willingness to quit smoking among patients with depressive and anxiety disorders seeking treatment.

Fatani B, Al-Yahyawi H, Raggam A, Al-Ahdal M, Alzyoud S, Hassan A Health Sci Rep. 2022; 5(2):e503.

PMID: 35229052 PMC: 8867423. DOI: 10.1002/hsr2.503.


Chronic nicotine exposure attenuates the effects of Δ -tetrahydrocannabinol on anxiety-related behavior and social interaction in adult male and female rats.

Manwell L, Miladinovic T, Raaphorst E, Rana S, Malecki S, Mallet P Brain Behav. 2019; 9(11):e01375.

PMID: 31583843 PMC: 6851810. DOI: 10.1002/brb3.1375.


Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives.

Guina J, Merrill B J Clin Med. 2018; 7(2).

PMID: 29385731 PMC: 5852433. DOI: 10.3390/jcm7020017.